Quality of life in patients with choroidal melanoma

To determine whether iodine 125 brachytherapy or enucleation is better for quality of life in patients treated for choroidal melanoma. Sixty-five patients with choroidal melanoma were treated with a modified version of VF-14 iodine 125 brachytherapy, enucleation or both. Results of this treatment we...

Full description

Saved in:
Bibliographic Details
Published inArchivos de la Sociedad Española de Oftalmología Vol. 83; no. 5; pp. 301 - 306
Main Authors Blanco-Rivera, C, Capeáns-Tomé, C, Otero-Cepeda, X L
Format Journal Article
LanguageSpanish
Published Spain 01.05.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To determine whether iodine 125 brachytherapy or enucleation is better for quality of life in patients treated for choroidal melanoma. Sixty-five patients with choroidal melanoma were treated with a modified version of VF-14 iodine 125 brachytherapy, enucleation or both. Results of this treatment were then statistically analyzed. Statistically significant differences were found between visual acuity in the affected eye and binocular vision (initial and final), with an important decline after the treatment. The global medial score in the VF questionnaire decreased in a statistically significant manner after the treatment. We can confirm that patients treated with brachytherapy had better health-related quality of life than those who had their eye enucleated and were more likely to have higher (better) scores on the VF questionnaire items. On the other hand, the binocular vision and time after the treatment correlated with the quality of life in long-term follow-up.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0365-6691